Regranex Gel 0.01% Gel
Product Images NDC 85822-734

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Regranex Gel 0.01% (NDC 85822-734). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lrm Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Image (25093 15g Carton V5)

Packaging label for Regranex Gel 0.01% (becaplermin gel 0.01%) topical gel, 15g tube. The label includes the product name, active ingredient strength, barcode, storage instructions to keep refrigerated at 2°-8°C and avoid freezing, manufacturer Lynch Regenerative Medicine LLC, and marketer LRM WoundCare, Inc. It features a colorful geometric design in blue, yellow, and purple tones, with clear indication of prescription only status (RX ONLY).*

FDA Label Image

Tube Image (25093 15g Tube V5)

Label for Regranex Gel 0.01% (becaplermin gel 0.01%), a topical human prescription drug in a 15 g tube. The label includes the active ingredient concentration (.1 mg/g), usage instructions for topical use only, storage details to refrigerate at 2-8°C, and manufacturer information from LRM Therapeutics, LLC. The design features the Regranex logo and associated graphics with a barcode and NDC 85822-734-15.*

FDA Label Image

Package Insert Figure 1 (Regranex Package Insert Figure 1)

A bar chart titled 'Incidence of Complete Diabetic Lower Extremity Ulcer Healing in Studies 1-4' comparing the percentage of ulcers healed across four studies. The chart includes data for Placebo Gel, REGRANEX Gel 0.003%, REGRANEX Gel 0.01%, and Good Ulcer Care Alone, each represented by different colored bars.*

FDA Label Image

Package Insert Table 3 (Regranex Package Insert Table 3)

A data table titled 'Life Table Estimates of the Incidence (%) of Complete Diabetic Lower Extremity Ulcer Healing over Time of Study 2.' It compares the percentage of ulcer healing incidence at various weeks from 2 to 20 between Regranex Gel 0.01% and placebo groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.